Karri Kuenzli Bradley, Ph.D.


Karri Kuenzli Bradley brings an extensive scientific background to helping clients obtain intellectual property rights in the United States and foreign jurisdictions. Her clients include many of the world’s most innovative universities, research institutions, and biotech companies.

Karri is a registered U.S. patent attorney with more than 15 years’ experience helping clients obtain patent rights in the biological and chemical sciences, with a particular emphasis on cancer biology, pharmacology, immunology, molecular biology, large and small molecules, and medical diagnostics/devices.

She represents domestic and international clients ranging from universities, research institutions, governmental entities, start-ups, to leaders in the biotechnology space. She has developed extensive patent portfolios for devices, diagnostic assays, compounds, and methods of treatment (e.g., cancer, infectious diseases, and muscular dystrophy) that have been licensed to large pharmaceutical companies, as well as spun out into start-ups.

Karri practices all aspects of intellectual property law. She successfully defended three inter partes reviews for Waveform Technologies, Inc. against Dexcom, Inc. involving analyte sensors and methods of use (Dexcom, Inc., v. Waveform Technologies, Inc., IPR2016-01679, IPR2016-016, and IPR2017-01051). Defending and asserting patents has made Karri a stronger patent prosecutor, as she better understands the pitfalls that need to be avoided during prosecution.

She also prepares opinions on patentability, inventorship, freedom-to-operate, non-infringement and invalidity, assists clients with due diligence analyses, trademark procurement and enforcement, patent and trademark licensing transactions, and Plant Variety Protection Act applications.

Karri holds a Ph.D. in Cellular and Molecular Pharmacology and Physiology and performed post-doctoral fellowships in pharmacology and molecular biology. This experience and her desire for continued learning and challenge translates to her commitment to understanding all aspects of a client’s business and goals and providing them with the best possible representation.



Representative Issued Patents

  • US 7,795,499 9/14/2012 Agrigenetics, Inc., entitled “Generation of Plants with Improved Drought Tolerance.”
  • US 8,193,145 6/5/2012 University of Nevada, Reno, entitled “Laminins, Derivatives, and Compositions Including Same and Methods for Their Therapeutic Use.”
  • US 8,187,622 5/29/2012 Marquet Cardiopulmonary AG, entitled “Use of Nonionic Esters in Coating for Surfaces Coming in contact with Blood.”
  • US 8,414,935 4.9/2013 Byzmed LLC, entitled “Composition and Methods for Clotting Blood.”
  • US 8,418,270 7/9/2013 Ventana Medical Systems, Inc., entitled “Method for Chromogenic Detection of Two or More Target Molecules in a Single Sample.”
  • US 8,426,146 4/23/2013 University of Pittsburgh-Of the Commonwealth System of Higher Education, entitled “Multiparametric Method for Assessing Immune System Status.”
  • US 8,496,798 7/30/2013 Oregon Health & Science University, entitled “Reversible Current Gel Electrophoresis Device for Separating Biological Macromolecules.”
  • US 8,532,778 9/10/2013 The United States of America as represented by the Department of Veterans Affairs, entitled “Restoring Cough Using Microstimulators.”
  • US 8,609,110 12/17/2013 University of Pittsburgh-Of the Commonwealth System of Higher Education and University of Medicine and Dentistry of New Jersey, entitled “CitroBacter Freundii Antibacterial Agents and Their Use.”
  • US 8,667,759 3/11/2014, Westblock Systems, Inc., entitled “Wall Block System.”
  • US 8,673,067 3/18/2014 Battelle Memorial Institute, entitled “Immobilized Fluid Membranes for Gas Separation.”
  • US 8,703,826 4/22/2014 The United States of America as represented by the Secretary of the Department of Health and Human Services, entitled “Preparation of (R,S)-fenoterol and (R,R)- or (R,S)-fenoterol Analogues and Their Use in Treating Congestive Heart Failure.”
  • US 8,921,071 12/30/2014 The United States of America as represented by the Secretary of the Department of Health and Human Services, entitled “Targeting Poly-Gamma-Glutamic Acid to Treat Staphylococcus Epidermidis and Related Infections.”
  • US 9,079,136 7/14/2015 Battelle Memorial Institute, entitled “Thin, Porous Metal Sheets and Methods for Making the Same.”
  • US 9,150,926 10/6/2015 The United States of America as represented by the Secretary of the Department of Health and Human Services, entitled “Diagnosis and Treatment of Adrenocortical Tumors Using Human MicroRNA-483.”
  • US 9,181,306 11/10/2015 The United States of America as represented by the Secretary of the Department of Health and Human Services, entitled “Insertion of Foreign Genes in Rubella Virus and Their Stable Expression in a Live, Attenuated Viral Vaccine.”
  • US 9,266,928 2/23/2016 The United States of America as represented by the Secretary of the Department of Health and Human Services, entitled “Deletion of the beta 20-21 loop in HIV GP120 Exposes the CDR Binding Site for Improved Antibody Binding and Antibody Induction.”

Memberships & Awards


  • Oregon State Bar Antitrust Section Committee, Member (2011-2015)
  • Association of University Technology Managers
  • Intellectual Property Section, Oregon State Bar, Member
  • American Intellectual Property Law Association, Member


  • Dean Merit Scholarship
  • Omaha Law League Scholarship
  • McKee Voorhees and Sease Scholarship
  • Cali Award recipient for Criminal Law, Marriage and Divorce, European Union Law, Patent Law, and Trademarks and Unfair Competition
  • Dean’s Honor Roll (Fall 2002, Spring 2003)
  • Sigma Xi Research Award (1994 and 1995)

Resources & Ideas

Seminars & Speaking Engagements

  • Co-author, “Purine Nucleoside-Dependent Inhibition of Cellular Proliferation in 1321N1 Human Astrocytoma Cells,” J. Pharmacol. Exp. Ther. (2001).
  • Co-author, “Kir3.1/3.2 Encodes an I(KACh)-like Current in Gastrointestinal Myocytes,” Am. J. Physiol. Gastrointest. Liver. Physiol. (2000).
  • Co-author, “Inward Rectifier Potassium Conductance Regulates Membrane Potential of Canine Colonic Smooth Muscle,” J. Physiol. (1999).
  • Co-author, “Kir2.1 Encodes the Inward Rectifier Potassium Channel in Rat Arterial Smooth Muscle Cells,” J. Physiol. (1999).
  • Co-author, “Molecular Diversity of K(V) Alpha- and Beta-Subunit Expression in Canine Gastrointestinal Smooth Muscles,” Am. J. Physiol. (1999).
  • Co-author, “Basal Activation of ATP-Sensitive Potassium Channels in Murine Colonic Smooth Muscle Cell,” Biophys. J. (1998).
  • Co-author, “Functional and Molecular Expression of Volume-Regulated Chloride Channels in Canine Vascular Smooth Muscle Cells,” J. Physiol. (1998).
  • Co-author, “Functional and Molecular Identification of a Novel Chloride Conductance in Canine Colonic Smooth Muscle,” Am. J. Physiol. (1998).
  • Co-author, “Nitric Oxide Regulation of Monkey Myometrial Contractility,” Br. J. Pharmacol. (1998).
  • Co-author, “Nitric Oxide Relaxes Human Myometrium by a cGMP-Independent Mechanism,” Am. J. Physiol. (1998).
  • Co-author, “Cyclic GMP-Independent Effects of Nitric Oxide on Guinea-Pig Uterine Contractility,” Br. J. Pharmacol. (1996).
  • Co-author, “Adenosine-Stimulated Contraction in Nonpregnant Guinea Pig Myometrium Does Not Involve Cyclooxygenase,” J. Pharmacol. Exp. Ther. (1993).

Community Activities

Community Activities

  • Saturday Academy, Board Member
  • Forest Grove Back to School Drive, Co-Chair (2010-2014)
  • Forest Grove Holiday Drive, Co-Chair (2009-2014)
  • Saturday Free Lunch Program at Vose Elementary School, Coordinator (2012-2014)
  • Oregon Food Bank Drive, Co-Chair (2010-2011)




Oregon State Courts

United States Patent and Trademark Office

Outside The Office